Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPLORER-CN: Mavacamten in Chinese Adults with Symptomatic oHCM
NCT05174416Phase 3Completed
- Sponsor
- LianBio
- Start
- Jan 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mavacamten in hypertrophic cardiomyopathy (HCM), sponsored by LianBio. Started Jan 2022; status: completed.
02
Drugs
mavacamten
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT05174416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05174416.